These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26367713)

  • 1. The expression features of serum Cystatin C and homocysteine of Parkinson's disease with mild cognitive dysfunction.
    Chen WW; Cheng X; Zhang X; Zhang QS; Sun HQ; Huang WJ; Xie ZY
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):2957-63. PubMed ID: 26367713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease.
    Li J; Gu C; Zhu M; Li D; Chen L; Zhu X
    Psychogeriatrics; 2020 Mar; 20(2):180-188. PubMed ID: 31828903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism.
    Zhang L; Yan J; Xu Y; Long L; Zhu C; Chen X; Jiang Y; Yang L; Bian L; Wang Q
    PLoS One; 2011 Apr; 6(4):e19333. PubMed ID: 21556377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Cystatin C Levels Are Associated with Cognitive Impairment and Progression of Parkinson Disease.
    Hu WD; Chen J; Mao CJ; Feng P; Yang YP; Luo WF; Liu CF
    Cogn Behav Neurol; 2016 Sep; 29(3):144-9. PubMed ID: 27662452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia influenced malnutrition in Parkinson's disease patients.
    Tomic S; Pekic V; Popijac Z; Pucic T; Vinkovic MP; Kuric TG; Popovic Z
    Neurol Sci; 2018 Oct; 39(10):1691-1695. PubMed ID: 29961201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
    Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
    Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications.
    Hassin-Baer S; Cohen O; Vakil E; Sela BA; Nitsan Z; Schwartz R; Chapman J; Tanne D
    Clin Neuropharmacol; 2006; 29(6):305-11. PubMed ID: 17095893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum homocysteine and physical exercise in patients with Parkinson's disease.
    Nascimento CM; Stella F; Garlipp CR; Santos RF; Gobbi S; Gobbi LT
    Psychogeriatrics; 2011 Jun; 11(2):105-12. PubMed ID: 21707858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions.
    Zoccolella S; Lamberti P; Iliceto G; Diroma C; Armenise E; Defazio G; Lamberti SV; Fraddosio A; de Mari M; Livrea P
    Clin Chem Lab Med; 2005; 43(10):1107-10. PubMed ID: 16197306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between homocysteine and third ventricle dilatation, mesencephalic area atrophy in Parkinson's disease with cognitive impairment.
    Fu XY; Zhang YC; Ding CW; Yang M; Song X; Wang CS; Chen XF; Zhang Y; Sheng YJ; Mao P; Mao CJ; Liu CF
    J Clin Neurosci; 2021 Aug; 90():273-278. PubMed ID: 34275563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia in patients with Parkinson's disease and relationship to vitamin B level.
    Shin HW; Sohn YH
    J Mov Disord; 2009 May; 2(1):33-6. PubMed ID: 24868350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of leukoaraiosis on the cognition of patients with Parkinson disease].
    Wang L; Zhu XQ; Jiang CJ; Chen XW; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):177-81. PubMed ID: 23570589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics in Parkinson's disease patients with cognitive impairment and effects of cognitive impairment on sleep].
    Gong Y; Xiong KP; Mao CJ; Huang JY; Hu WD; Han F; Chen R; Liu CF
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2637-41. PubMed ID: 24360043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
    Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
    West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Xie Y; Feng H; Peng S; Xiao J; Zhang J
    Neurosci Lett; 2017 Jan; 636():190-195. PubMed ID: 27840145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.
    Camicioli RM; Bouchard TP; Somerville MJ
    Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation on plasma homocysteine level and cognition in population at high risk for stroke in Xi'an].
    Ma H; Yan F; Li Z; Deng M; Qu Q; ;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jul; 35(7):769-72. PubMed ID: 25301241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations.
    O'Suilleabhain PE; Sung V; Hernandez C; Lacritz L; Dewey RB; Bottiglieri T; Diaz-Arrastia R
    Arch Neurol; 2004 Jun; 61(6):865-8. PubMed ID: 15210523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.